webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

N3Ac-OPhOMe

  CAS No.: 2546513-31-7   Cat No.: BADC-01763 4.5  

N3Ac-OPhOMe is an azidoacetyl ester ADC linker intermediate enabling bioorthogonal click conjugation in antibody-drug conjugates for site-specific payload attachment and improved therapeutic efficacy. Keywords: ADC linker, azidoacetyl linker, bioorthogonal chemistry, payload conjugation, targeted therapy.

N3Ac-OPhOMe

Structure of 2546513-31-7

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C9H9N3O3
Molecular Weight
207.19

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
IUPAC Name
(4-methoxyphenyl) 2-azidoacetate
Canonical SMILES
COC1=CC=C(C=C1)OC(=O)CN=[N+]=[N-]
InChI
InChI=1S/C9H9N3O3/c1-14-7-2-4-8(5-3-7)15-9(13)6-11-12-10/h2-5H,6H2,1H3
InChIKey
CBCXKHGBUBDDQO-UHFFFAOYSA-N

N3Ac-OPhOMe, also known as N-acetyl-3-(methoxyphenyl)propionamide, is a chemical compound that combines an acetyl group with a methoxyphenyl group attached to a propionamide backbone. This structure imparts a range of useful properties, including enhanced solubility, reactivity, and stability, making it valuable in various chemical and pharmaceutical applications. Its design allows for specific interactions with biological systems, positioning it as an important building block in medicinal chemistry, bioconjugation, and material science.

One of the primary applications of N3Ac-OPhOMe is in the development of drug molecules and prodrugs. The acetyl group enhances the lipophilicity and membrane permeability of the compound, which can facilitate the targeted delivery of bioactive molecules. In particular, N3Ac-OPhOMe can be used as a precursor or intermediate in the synthesis of drugs designed to target specific diseases, such as cancer or infections. The methoxyphenyl group can provide additional specificity for binding to particular proteins or receptors, thereby improving the selectivity of the drug and reducing off-target effects.

Another significant application of N3Ac-OPhOMe is in enzyme inhibition and bioactive compound screening. The compound can be modified to include reactive groups capable of interacting with the active sites of enzymes, which could lead to the design of enzyme inhibitors with therapeutic potential. By using N3Ac-OPhOMe as part of high-throughput screening assays, researchers can identify potential drug candidates that modulate enzyme activity, especially in the context of diseases where enzymes play critical roles, such as in cancer metastasis or inflammatory processes. This makes N3Ac-OPhOMe valuable in the discovery of novel therapeutics.

N3Ac-OPhOMe is also useful in chemical synthesis, particularly as a reagent in organic reactions. The presence of the methoxyphenyl and acetyl groups enables the compound to participate in reactions such as nucleophilic substitutions, acylation, and alkylation. These reactions are essential for the synthesis of complex organic molecules, including those used in pharmaceuticals, agrochemicals, and fine chemicals. Additionally, the compound’s versatility in synthetic chemistry makes it an important tool for researchers working on the development of new chemical processes or materials.

In the realm of material science, N3Ac-OPhOMe can serve as a precursor for the preparation of functional polymers or coatings. The chemical structure of N3Ac-OPhOMe allows it to be incorporated into polymer chains or used in the synthesis of crosslinked networks. This makes it applicable in the development of coatings with specific properties, such as antimicrobial activity, controlled release, or surface modification. By tuning the properties of the methoxyphenyl and acetyl groups, the material’s mechanical, chemical, or thermal stability can be optimized for various industrial applications.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: SC209 | Biotin-PEG3-aldehyde | SC209 intermediate-1 | DACN(Ms,Ns) | N3-Gly-Gly-Gly-Gly-Gly-OH | Tetra-O-acetyl-β-D-galactopyranosyl-Ph-CH2-(4-nitrophenyl)carbonate-Fmoc | Norbornene-NHS | beta-Lac-TEG-N3 | N3-TOTA-Suc | Bz-(Me)Tz-NHS | N3Ac-OPhOMe
Send Inquiry
Verification code
Inquiry Basket